Langenbeck's Archives of Surgery · Nov 18, 2026
Single-center experience with sasi bypass: mid-term outcomes and technical evolution
By Romero RJ, Ravell MCN, Aguirre-Paez S et al.
Purpose To evaluate the feasibility, safety, and metabolic outcomes of the Single Anastomosis Sleeve Ileal (SASI) bypass in patients undergoing primary metabolic and bariatric surgery at our institution, expanding upon previous data. Methods A retrospective cohort study was conducted including patients who underwent SASI bypass as a primary procedure. Primary outcomes included %EWL and remission rates of T2DM, hypertension, dyslipidemia, and other obesity-related diseases. Complications were classified using the Clavien–Dindo system. Surgical technique modifications were analyzed for their impact on outcomes. A subset of patients was followed for more than three years, allowing mid-term outcome evaluation. Results Mean %TWL 33.0%. Remission rates for T2DM, hypertension, and dyslipidemia were 78.3%, 89.1%, and 85.6%, respectively. GERD symptoms improved in all affected patients, with 57.9% achieving complete remission. The overall complication rate was 13.1%, with a 3.6% reoperation rate, and most adverse events occurred early in the study period. Technical modifications, including reduction of anastomosis size and adjustment of limb length, were associated with lower %EWL but decreased complication rates. Conclusions SASI bypass is a safe and effective metabolic procedure, demonstrating encouraging outcomes in weight loss and diabetes remission, with emerging evidence of GERD improvement. Anastomosis size (≤ 2.5–3 cm) and alimentary limb length (≈ 3–3.5 m) are key factors in balancing efficacy and nutritional risk. Further studies are needed to define the optimal configuration and long-term outcomes. Graphical Abstract